CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: TUMOR ABLATION MARKET, BY TECHNOLOGY
4.1 Overview
4.1.1 Market size and forecast
4.2 Radiofrequency Ablation
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Microwave Ablation
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.4 Cryoablation
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
4.5 Irreversible Electroporation Ablation
4.5.1 Key market trends, growth factors and opportunities
4.5.2 Market size and forecast, by region
4.5.3 Market analysis by country
4.6 Other Ablation Technologies
4.6.1 Key market trends, growth factors and opportunities
4.6.2 Market size and forecast, by region
4.6.3 Market analysis by country
CHAPTER 5: TUMOR ABLATION MARKET, BY TREATMENT
5.1 Overview
5.1.1 Market size and forecast
5.2 Surgical Ablation
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Laparoscopic Ablation
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Percutaneous Ablation
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
CHAPTER 6: TUMOR ABLATION MARKET, BY APPLICATION
6.1 Overview
6.1.1 Market size and forecast
6.2 Kidney Cancer
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Liver Cancer
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
6.4 Breast Cancer
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market analysis by country
6.5 Lung Cancer
6.5.1 Key market trends, growth factors and opportunities
6.5.2 Market size and forecast, by region
6.5.3 Market analysis by country
6.6 Prostate Cancer
6.6.1 Key market trends, growth factors and opportunities
6.6.2 Market size and forecast, by region
6.6.3 Market analysis by country
CHAPTER 7: TUMOR ABLATION MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Technology
7.2.3 North America Market size and forecast, by Treatment
7.2.4 North America Market size and forecast, by Application
7.2.5 North America Market size and forecast, by country
7.2.5.1 U.S.
7.2.5.1.1 Market size and forecast, by Technology
7.2.5.1.2 Market size and forecast, by Treatment
7.2.5.1.3 Market size and forecast, by Application
7.2.5.2 Canada
7.2.5.2.1 Market size and forecast, by Technology
7.2.5.2.2 Market size and forecast, by Treatment
7.2.5.2.3 Market size and forecast, by Application
7.2.5.3 Mexico
7.2.5.3.1 Market size and forecast, by Technology
7.2.5.3.2 Market size and forecast, by Treatment
7.2.5.3.3 Market size and forecast, by Application
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Technology
7.3.3 Europe Market size and forecast, by Treatment
7.3.4 Europe Market size and forecast, by Application
7.3.5 Europe Market size and forecast, by country
7.3.5.1 Germany
7.3.5.1.1 Market size and forecast, by Technology
7.3.5.1.2 Market size and forecast, by Treatment
7.3.5.1.3 Market size and forecast, by Application
7.3.5.2 France
7.3.5.2.1 Market size and forecast, by Technology
7.3.5.2.2 Market size and forecast, by Treatment
7.3.5.2.3 Market size and forecast, by Application
7.3.5.3 United Kingdom
7.3.5.3.1 Market size and forecast, by Technology
7.3.5.3.2 Market size and forecast, by Treatment
7.3.5.3.3 Market size and forecast, by Application
7.3.5.4 Italy
7.3.5.4.1 Market size and forecast, by Technology
7.3.5.4.2 Market size and forecast, by Treatment
7.3.5.4.3 Market size and forecast, by Application
7.3.5.5 Spain
7.3.5.5.1 Market size and forecast, by Technology
7.3.5.5.2 Market size and forecast, by Treatment
7.3.5.5.3 Market size and forecast, by Application
7.3.5.6 Rest of Europe
7.3.5.6.1 Market size and forecast, by Technology
7.3.5.6.2 Market size and forecast, by Treatment
7.3.5.6.3 Market size and forecast, by Application
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Technology
7.4.3 Asia-Pacific Market size and forecast, by Treatment
7.4.4 Asia-Pacific Market size and forecast, by Application
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 Japan
7.4.5.1.1 Market size and forecast, by Technology
7.4.5.1.2 Market size and forecast, by Treatment
7.4.5.1.3 Market size and forecast, by Application
7.4.5.2 China
7.4.5.2.1 Market size and forecast, by Technology
7.4.5.2.2 Market size and forecast, by Treatment
7.4.5.2.3 Market size and forecast, by Application
7.4.5.3 Australia
7.4.5.3.1 Market size and forecast, by Technology
7.4.5.3.2 Market size and forecast, by Treatment
7.4.5.3.3 Market size and forecast, by Application
7.4.5.4 India
7.4.5.4.1 Market size and forecast, by Technology
7.4.5.4.2 Market size and forecast, by Treatment
7.4.5.4.3 Market size and forecast, by Application
7.4.5.5 South Korea
7.4.5.5.1 Market size and forecast, by Technology
7.4.5.5.2 Market size and forecast, by Treatment
7.4.5.5.3 Market size and forecast, by Application
7.4.5.6 Rest of Asia-Pacific
7.4.5.6.1 Market size and forecast, by Technology
7.4.5.6.2 Market size and forecast, by Treatment
7.4.5.6.3 Market size and forecast, by Application
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Technology
7.5.3 LAMEA Market size and forecast, by Treatment
7.5.4 LAMEA Market size and forecast, by Application
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Brazil
7.5.5.1.1 Market size and forecast, by Technology
7.5.5.1.2 Market size and forecast, by Treatment
7.5.5.1.3 Market size and forecast, by Application
7.5.5.2 Saudi Arabia
7.5.5.2.1 Market size and forecast, by Technology
7.5.5.2.2 Market size and forecast, by Treatment
7.5.5.2.3 Market size and forecast, by Application
7.5.5.3 South Africa
7.5.5.3.1 Market size and forecast, by Technology
7.5.5.3.2 Market size and forecast, by Treatment
7.5.5.3.3 Market size and forecast, by Application
7.5.5.4 Rest of LAMEA
7.5.5.4.1 Market size and forecast, by Technology
7.5.5.4.2 Market size and forecast, by Treatment
7.5.5.4.3 Market size and forecast, by Application
CHAPTER 8: COMPANY LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments
CHAPTER 9: COMPANY PROFILES
9.1 Medtronic, Inc.
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Product portfolio
9.1.5 Business performance
9.1.6 Key strategic moves and developments
9.2 Boston Scientific Corporation
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Product portfolio
9.2.5 Business performance
9.2.6 Key strategic moves and developments
9.3 Smith+Nephew
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Product portfolio
9.3.5 Business performance
9.3.6 Key strategic moves and developments
9.4 Integra Life sciences
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Product portfolio
9.4.5 Business performance
9.4.6 Key strategic moves and developments
9.5 Angidynamics
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Product portfolio
9.5.5 Business performance
9.5.6 Key strategic moves and developments
9.6 Johnson and johnson
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Product portfolio
9.6.5 Business performance
9.6.6 Key strategic moves and developments
9.7 ethicon, inc.
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Product portfolio
9.7.5 Business performance
9.7.6 Key strategic moves and developments
9.8 Galil Medical Inc.
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Product portfolio
9.8.5 Business performance
9.8.6 Key strategic moves and developments
9.9 Misonix Inc.
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Product portfolio
9.9.5 Business performance
9.9.6 Key strategic moves and developments
9.10 HealthTronics
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Operating business segments
9.10.4 Product portfolio
9.10.5 Business performance
9.10.6 Key strategic moves and developments
TABLE 1. GLOBAL TUMOR ABLATION MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 2. TUMOR ABLATION MARKET SIZE, FOR RADIOFREQUENCY ABLATION, BY REGION, 2021-2031 ($MILLION)
TABLE 3. TUMOR ABLATION MARKET FOR RADIOFREQUENCY ABLATION BY COUNTRY, 2021-2031 ($MILLION)
TABLE 4. TUMOR ABLATION MARKET SIZE, FOR MICROWAVE ABLATION, BY REGION, 2021-2031 ($MILLION)
TABLE 5. TUMOR ABLATION MARKET FOR MICROWAVE ABLATION BY COUNTRY, 2021-2031 ($MILLION)
TABLE 6. TUMOR ABLATION MARKET SIZE, FOR CRYOABLATION, BY REGION, 2021-2031 ($MILLION)
TABLE 7. TUMOR ABLATION MARKET FOR CRYOABLATION BY COUNTRY, 2021-2031 ($MILLION)
TABLE 8. TUMOR ABLATION MARKET SIZE, FOR IRREVERSIBLE ELECTROPORATION ABLATION, BY REGION, 2021-2031 ($MILLION)
TABLE 9. TUMOR ABLATION MARKET FOR IRREVERSIBLE ELECTROPORATION ABLATION BY COUNTRY, 2021-2031 ($MILLION)
TABLE 10. TUMOR ABLATION MARKET SIZE, FOR OTHER ABLATION TECHNOLOGIES, BY REGION, 2021-2031 ($MILLION)
TABLE 11. TUMOR ABLATION MARKET FOR OTHER ABLATION TECHNOLOGIES BY COUNTRY, 2021-2031 ($MILLION)
TABLE 12. GLOBAL TUMOR ABLATION MARKET, BY TREATMENT, 2021-2031 ($MILLION)
TABLE 13. TUMOR ABLATION MARKET SIZE, FOR SURGICAL ABLATION, BY REGION, 2021-2031 ($MILLION)
TABLE 14. TUMOR ABLATION MARKET FOR SURGICAL ABLATION BY COUNTRY, 2021-2031 ($MILLION)
TABLE 15. TUMOR ABLATION MARKET SIZE, FOR LAPAROSCOPIC ABLATION, BY REGION, 2021-2031 ($MILLION)
TABLE 16. TUMOR ABLATION MARKET FOR LAPAROSCOPIC ABLATION BY COUNTRY, 2021-2031 ($MILLION)
TABLE 17. TUMOR ABLATION MARKET SIZE, FOR PERCUTANEOUS ABLATION, BY REGION, 2021-2031 ($MILLION)
TABLE 18. TUMOR ABLATION MARKET FOR PERCUTANEOUS ABLATION BY COUNTRY, 2021-2031 ($MILLION)
TABLE 19. GLOBAL TUMOR ABLATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 20. TUMOR ABLATION MARKET SIZE, FOR KIDNEY CANCER, BY REGION, 2021-2031 ($MILLION)
TABLE 21. TUMOR ABLATION MARKET FOR KIDNEY CANCER BY COUNTRY, 2021-2031 ($MILLION)
TABLE 22. TUMOR ABLATION MARKET SIZE, FOR LIVER CANCER, BY REGION, 2021-2031 ($MILLION)
TABLE 23. TUMOR ABLATION MARKET FOR LIVER CANCER BY COUNTRY, 2021-2031 ($MILLION)
TABLE 24. TUMOR ABLATION MARKET SIZE, FOR BREAST CANCER, BY REGION, 2021-2031 ($MILLION)
TABLE 25. TUMOR ABLATION MARKET FOR BREAST CANCER BY COUNTRY, 2021-2031 ($MILLION)
TABLE 26. TUMOR ABLATION MARKET SIZE, FOR LUNG CANCER, BY REGION, 2021-2031 ($MILLION)
TABLE 27. TUMOR ABLATION MARKET FOR LUNG CANCER BY COUNTRY, 2021-2031 ($MILLION)
TABLE 28. TUMOR ABLATION MARKET SIZE, FOR PROSTATE CANCER, BY REGION, 2021-2031 ($MILLION)
TABLE 29. TUMOR ABLATION MARKET FOR PROSTATE CANCER BY COUNTRY, 2021-2031 ($MILLION)
TABLE 30. TUMOR ABLATION MARKET, BY REGION, 2021-2031 ($MILLION)
TABLE 31. NORTH AMERICA TUMOR ABLATION MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 32. NORTH AMERICA TUMOR ABLATION MARKET, BY TREATMENT, 2021-2031 ($MILLION)
TABLE 33. NORTH AMERICA TUMOR ABLATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 34. NORTH AMERICA TUMOR ABLATION MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 35. U.S. TUMOR ABLATION MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 36. U.S. TUMOR ABLATION MARKET, BY TREATMENT, 2021-2031 ($MILLION)
TABLE 37. U.S. TUMOR ABLATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 38. CANADA TUMOR ABLATION MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 39. CANADA TUMOR ABLATION MARKET, BY TREATMENT, 2021-2031 ($MILLION)
TABLE 40. CANADA TUMOR ABLATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 41. MEXICO TUMOR ABLATION MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 42. MEXICO TUMOR ABLATION MARKET, BY TREATMENT, 2021-2031 ($MILLION)
TABLE 43. MEXICO TUMOR ABLATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 44. EUROPE TUMOR ABLATION MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 45. EUROPE TUMOR ABLATION MARKET, BY TREATMENT, 2021-2031 ($MILLION)
TABLE 46. EUROPE TUMOR ABLATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 47. EUROPE TUMOR ABLATION MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 48. GERMANY TUMOR ABLATION MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 49. GERMANY TUMOR ABLATION MARKET, BY TREATMENT, 2021-2031 ($MILLION)
TABLE 50. GERMANY TUMOR ABLATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 51. FRANCE TUMOR ABLATION MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 52. FRANCE TUMOR ABLATION MARKET, BY TREATMENT, 2021-2031 ($MILLION)
TABLE 53. FRANCE TUMOR ABLATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 54. UNITED KINGDOM TUMOR ABLATION MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 55. UNITED KINGDOM TUMOR ABLATION MARKET, BY TREATMENT, 2021-2031 ($MILLION)
TABLE 56. UNITED KINGDOM TUMOR ABLATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 57. ITALY TUMOR ABLATION MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 58. ITALY TUMOR ABLATION MARKET, BY TREATMENT, 2021-2031 ($MILLION)
TABLE 59. ITALY TUMOR ABLATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 60. SPAIN TUMOR ABLATION MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 61. SPAIN TUMOR ABLATION MARKET, BY TREATMENT, 2021-2031 ($MILLION)
TABLE 62. SPAIN TUMOR ABLATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 63. REST OF EUROPE TUMOR ABLATION MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 64. REST OF EUROPE TUMOR ABLATION MARKET, BY TREATMENT, 2021-2031 ($MILLION)
TABLE 65. REST OF EUROPE TUMOR ABLATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 66. ASIA-PACIFIC TUMOR ABLATION MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 67. ASIA-PACIFIC TUMOR ABLATION MARKET, BY TREATMENT, 2021-2031 ($MILLION)
TABLE 68. ASIA-PACIFIC TUMOR ABLATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 69. ASIA-PACIFIC TUMOR ABLATION MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 70. JAPAN TUMOR ABLATION MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 71. JAPAN TUMOR ABLATION MARKET, BY TREATMENT, 2021-2031 ($MILLION)
TABLE 72. JAPAN TUMOR ABLATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 73. CHINA TUMOR ABLATION MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 74. CHINA TUMOR ABLATION MARKET, BY TREATMENT, 2021-2031 ($MILLION)
TABLE 75. CHINA TUMOR ABLATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 76. AUSTRALIA TUMOR ABLATION MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 77. AUSTRALIA TUMOR ABLATION MARKET, BY TREATMENT, 2021-2031 ($MILLION)
TABLE 78. AUSTRALIA TUMOR ABLATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 79. INDIA TUMOR ABLATION MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 80. INDIA TUMOR ABLATION MARKET, BY TREATMENT, 2021-2031 ($MILLION)
TABLE 81. INDIA TUMOR ABLATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 82. SOUTH KOREA TUMOR ABLATION MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 83. SOUTH KOREA TUMOR ABLATION MARKET, BY TREATMENT, 2021-2031 ($MILLION)
TABLE 84. SOUTH KOREA TUMOR ABLATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 85. REST OF ASIA-PACIFIC TUMOR ABLATION MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 86. REST OF ASIA-PACIFIC TUMOR ABLATION MARKET, BY TREATMENT, 2021-2031 ($MILLION)
TABLE 87. REST OF ASIA-PACIFIC TUMOR ABLATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 88. LAMEA TUMOR ABLATION MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 89. LAMEA TUMOR ABLATION MARKET, BY TREATMENT, 2021-2031 ($MILLION)
TABLE 90. LAMEA TUMOR ABLATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 91. LAMEA TUMOR ABLATION MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 92. BRAZIL TUMOR ABLATION MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 93. BRAZIL TUMOR ABLATION MARKET, BY TREATMENT, 2021-2031 ($MILLION)
TABLE 94. BRAZIL TUMOR ABLATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 95. SAUDI ARABIA TUMOR ABLATION MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 96. SAUDI ARABIA TUMOR ABLATION MARKET, BY TREATMENT, 2021-2031 ($MILLION)
TABLE 97. SAUDI ARABIA TUMOR ABLATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 98. SOUTH AFRICA TUMOR ABLATION MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 99. SOUTH AFRICA TUMOR ABLATION MARKET, BY TREATMENT, 2021-2031 ($MILLION)
TABLE 100. SOUTH AFRICA TUMOR ABLATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 101. REST OF LAMEA TUMOR ABLATION MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 102. REST OF LAMEA TUMOR ABLATION MARKET, BY TREATMENT, 2021-2031 ($MILLION)
TABLE 103. REST OF LAMEA TUMOR ABLATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 104.MEDTRONIC, INC.: COMPANY SNAPSHOT
TABLE 105.MEDTRONIC, INC.: OPERATING SEGMENTS
TABLE 106.MEDTRONIC, INC.: PRODUCT PORTFOLIO
TABLE 107.MEDTRONIC, INC.: NET SALES,
TABLE 108.MEDTRONIC, INC.: KEY STRATERGIES
TABLE 109.BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
TABLE 110.BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
TABLE 111.BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
TABLE 112.BOSTON SCIENTIFIC CORPORATION: NET SALES,
TABLE 113.BOSTON SCIENTIFIC CORPORATION: KEY STRATERGIES
TABLE 114.SMITH+NEPHEW: COMPANY SNAPSHOT
TABLE 115.SMITH+NEPHEW: OPERATING SEGMENTS
TABLE 116.SMITH+NEPHEW: PRODUCT PORTFOLIO
TABLE 117.SMITH+NEPHEW: NET SALES,
TABLE 118.SMITH+NEPHEW: KEY STRATERGIES
TABLE 119.INTEGRA LIFE SCIENCES: COMPANY SNAPSHOT
TABLE 120.INTEGRA LIFE SCIENCES: OPERATING SEGMENTS
TABLE 121.INTEGRA LIFE SCIENCES: PRODUCT PORTFOLIO
TABLE 122.INTEGRA LIFE SCIENCES: NET SALES,
TABLE 123.INTEGRA LIFE SCIENCES: KEY STRATERGIES
TABLE 124.ANGIDYNAMICS: COMPANY SNAPSHOT
TABLE 125.ANGIDYNAMICS: OPERATING SEGMENTS
TABLE 126.ANGIDYNAMICS: PRODUCT PORTFOLIO
TABLE 127.ANGIDYNAMICS: NET SALES,
TABLE 128.ANGIDYNAMICS: KEY STRATERGIES
TABLE 129.JOHNSON AND JOHNSON: COMPANY SNAPSHOT
TABLE 130.JOHNSON AND JOHNSON: OPERATING SEGMENTS
TABLE 131.JOHNSON AND JOHNSON: PRODUCT PORTFOLIO
TABLE 132.JOHNSON AND JOHNSON: NET SALES,
TABLE 133.JOHNSON AND JOHNSON: KEY STRATERGIES
TABLE 134.ETHICON, INC.: COMPANY SNAPSHOT
TABLE 135.ETHICON, INC.: OPERATING SEGMENTS
TABLE 136.ETHICON, INC.: PRODUCT PORTFOLIO
TABLE 137.ETHICON, INC.: NET SALES,
TABLE 138.ETHICON, INC.: KEY STRATERGIES
TABLE 139.GALIL MEDICAL INC.: COMPANY SNAPSHOT
TABLE 140.GALIL MEDICAL INC.: OPERATING SEGMENTS
TABLE 141.GALIL MEDICAL INC.: PRODUCT PORTFOLIO
TABLE 142.GALIL MEDICAL INC.: NET SALES,
TABLE 143.GALIL MEDICAL INC.: KEY STRATERGIES
TABLE 144.MISONIX INC.: COMPANY SNAPSHOT
TABLE 145.MISONIX INC.: OPERATING SEGMENTS
TABLE 146.MISONIX INC.: PRODUCT PORTFOLIO
TABLE 147.MISONIX INC.: NET SALES,
TABLE 148.MISONIX INC.: KEY STRATERGIES
TABLE 149.HEALTHTRONICS: COMPANY SNAPSHOT
TABLE 150.HEALTHTRONICS: OPERATING SEGMENTS
TABLE 151.HEALTHTRONICS: PRODUCT PORTFOLIO
TABLE 152.HEALTHTRONICS: NET SALES,
TABLE 153.HEALTHTRONICS: KEY STRATERGIES
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
